30403047
0019-9567/00/$04.000
Copyright 2000, American Society for Microbiology. All Rights Reserved.
Two novel putative Escherichia coli virulence genes, iha and iroN from E. coli (iroNE. coli), were detected in 55
and 39%, respectively, of 67 E. coli isolates from patients with urosepsis. iha and iroNE. coli exhibited divergent
associations with other putative virulence genes, phylogenetic markers, host characteristics, and antimicrobial
resistance.
gene) and allele II of papG (the P fimbrial digalactoside-specific adhesin gene) (8, 16, 17). Consistent with the hypothesis
that iha is a PVF in ExPEC, probes derived from PAI regions
immediately adjacent to iha as it occurs in strain CFT073
hybridized significantly more frequent with UTI or bacteremia
isolates of E. coli than with commensal E. coli (8).
iroNE. coli, a novel catechole siderophore receptor which
exhibits increased expression in urine, was recently identified
in archetypal ExPEC strain CP9 as part of a PAI which also
includes one of this strains two pap operons (i.e., the pap
operon containing the F14 papA allele and papG allele III),
cnf1 (named for cytotoxic necrotizing factor 1), hly, and foc
(F1C fimbriae) (16, 23). iroNE. coli, like iha, was also found by
probe hybridization to be more prevalent among E. coli isolates from patients with UTI or bacteremia than among commensal strains, consistent with its being a VF in extraintestinal
infections (23).
In the present study, we used PCR- and probe hybridizationbased gene detection to determine the prevalence of iha and
iroNE. coli within a well-characterized collection of E. coli blood
isolates from patients with urosepsis. By comparing newly determined results for iha and iroNE. coli with previously determined extended PVF genotypes (15), O:K:H serotypes (13),
carboxylesterase B electrophoretic types (which reflect membership in virulence-associated phylogenetic group B2 versus
in other phylogenetic groups) (11), antimicrobial resistance
profiles (12), and host compromise data (12), we were able to
define and compare the associations of iha and iroNE. coli with
these other factors. We present data demonstrating that iha
and iroNE. coli exhibit widely divergent associations with all of
the above factors and are not consistently linked even with
PVFs from their own presumed PAIs of origin.
Strains. The clinical collection studied comprised 67 wellcharacterized blood culture isolates of E. coli collected from
adults with urosepsis in Seattle, Wash., in the mid-1980s (12).
The status of these strains with respect to multiple characteristics has been reported previously (1013, 15). (Eight strains
from the 75-member collection which exhibited amplification
fingerprints inconsistent with their putative O:K:H serotype
and carboxylesterase B type in experiments not yet published
3041
NOTES
O2:K5:H1
O2:K7:H
O2:K7:H
O2:K7:H
O2:K7:H1
O4:K12:H1
O4:K12:H
R:K12:H1
B2
B2
B2
B2
B2
NAc
B2
B2
B2
B2
B2
B2
B2
B2
B2
B2
B2
B2
B2
B2
B2
B2
B2
B2
B2
B2
B2
B2
B2
V27
H19
V6
V24
H1
V31
PM8
V7
H26
V5
U3
PM4
PM5
2H4
2H24
V1
V3
V16
V19
V22
H3
U5
U7
H9
U4
PM2
H7
2H25
H5
II
II
II
II
III
II
III
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II,III
II
II
II
II
II
II
II
II
II
II
II
II
II
III
F7-1
O16:K1:H
Adhesin
Toxin
Siderophore
d
d
d
d
d
d
d
d
d
d
kpsMT kpsMT
G
sfa/
afa/
K1 K5 rfc cvaC traT ibeA
sfaS focG
iha bmaE gafD hlyA cnf1 cdtB iroNE. coli fyuA iutA
II
III
allele(s) focDE
draBC
O18ac:K1:H7 F10
F48
O6:K?:H
O12:K1:H6
O12:K1:H6
R:K1:H6
F11
F10, F14
F10, F13
F10, F13
O6:K5:H
O6:K5:H
O6:K53:H7
O6:K53:H7
F7-2
F7-2
F7-2
F7-2
F7-2
F7-2
F7-2
F7-2
F7-2
F7-2
F10, F11
F10, F11
F10, F11, F16
F10, F14
F10, F14
F10, F14
F7-1, F10
F10, F12, F15
F11
F11
F11
F11
F11
F11
F11
F11
F11
F11
F-type
O6:K2:H1
O6:K2:H1
O6:K2:H1
O6:K2:H1
O6:K2:H1
O6:K2:H1
O6:K2:H1
O6:H1
O6:K2:H?
R:K2:H1
O2:K1:H7
O2:K1:H7
O2:K1:H7
O2:K1:H7
R:K1:H7
B2
B2
B2
B2
B2
H15
H25
PM6
2P6
H35
O1:K1:H7
O1:K1:H7
O1:K1:H7
O1:K1:H7
O1:K1:H7
B2
B2
B2
B2
B2
H16
H38
V15
V23
2H18
O:K:H
serotype
coli
Miscellaneous
(PAI)
NOTES
Strain CBTb
B2
B2
B2
B2
B1
B1
B1
B1
B1
B1
B1
B1
B1
B1
B1
B1
B1
B1
B1
B1
B1
B1
B1
B1
B1
B1
B1
V21
2H19
V8
PM3
V14
V20
V29
PM7
H27
U6
U1
V28
V9
PM9
V26
V32
2H17
2P9
V11
2H16
H8
H17
PM1
V10
V12
H2
H18
O77:K54:H18 NEG
O84:H
F16
NEG
NEG
NEG
O157:K52:H45 F16
O157:H32
O64:H21
O25:K16:H4
F16
F16
II
II
II
II
O25:K2:H2
O25:K2:H2
O17:K53:H18 NEG
F16
F16
O15:K52:H1
O15:K52:H1
II
II
III
II
II
II
II
II
II
II
II
F14
O15,O40:K
NEG
NEG
O9:K34:H
O9:K34:H
F11
NEG
O8:K:H
O9:K36:H19
NEG
F11
NEG
O8:K27:H
O8:K27:H
O8:K44:H9
F10
F40
F10
O7:K1:H
O7:K1:H
O7:H
O2:K5:H
F10, F48
F10
O75:K:H
F10
F8, F10
F10
O75:K5:H5
O75:K5:H5
O75:K5:H
O21:K100:H5 F7-2
d
d
NOTES
The presence () or absence () of the indicated gene in isolates is shown. The iha and iroN data are shown in bold type for emphasis. Data are adapted from reference 15, with permission.
b
CBT, carboxylesterase B type.
c
NA, not applicable.
d
Negative by PCR but positive by probe for kpsMT II.
e
NEG, no F-type adhesin.
B2
2H21
3044
NOTES
INFECT. IMMUN.
TABLE 2. Distribution of other PVFs according to the presence or absence of iha and iroNE.
coli
iha
Present
(n 37)
Absent
(n 30)
55 (82)
53 (79)
49 (73)
5 (7)
18 (27)
3 (4)
13 (19)
4 (6)
4 (6)
1 (1)
29 (43)
12 (18)
6 (9)
63 (94)
52 (77)
35 (95)
34 (92)
34 (92)
1 (5)
13 (35)
0
12 (33)
4 (11)
0
0
22 (59)
6 (16)
5 (14)
37 (100)
37 (100)
20 (67)
19 (63)
15 (50)
4 (13)
5 (17)
3 (10)
1 (3)
0
4 (13)
1 (3)
7 (23)
6 (20)
1 (3)
26 (87)
15 (50)
13 (19)
39 (58)
56 (84)
19 (28)
12 (18)
25 (33)
1 (1)
3 (4)
4 (6)
9 (13)
44 (66)
48 (72)
29 (39)
1 (3)
36 (97)
36 (97)
6 (16)
11 (30)
19 (51)
0
2 (5)
1 (3)
0
21 (57)
30 (81)
13 (35)
12 (40)
3 (10)
20 (67)
13 (43)
1 (3)
6 (20)
1 (3)
1 (13)
3 (10)
9 (30)
23 (77)
18 (60)
13 (43)
iroNE. coli
Present
(n 26)
P valueb
0.004
0.006
0.001
(0.08)
0.004
(0.036)
0.006
0.036
0.001
(0.001)
0.001
0.002
(0.03)
0.008
0.01
(0.001)
0.10
22 (85)
22 (85)
19 (73)
4 (15)
18 (69)
3 (12)
13 (50)
0
2 (8)
1 (4)
17 (65)
10 (38)
4 (15)
26 (100)
21 (81)
8 (31)
13 (50)
21 (81)
5 (19)
6 (23)
10 (38)
0
2 (8)
3 (12)
8 (31)
16 (62)
21 (81)
NAc
Absent
(n 41)
P value
33 (80)
31 (76)
30 (73)
1 (2)
0
0
0
4 (10)
2 (5)
0
12 (29)
2 (5)
2 (5)
37 (90)
31 (76)
0.07
0.001
0.054
0.001
0.005
0.001
5 (12)
26 (63)
35 (85)
14 (34)
6 (15)
15 (37)
1 (2)
1 (2)
1 (2)
1 (2)
28 (68)
27 (66)
NA
0.002
a
As determined by PCR only (K1 and K5), probe only (plasmid aerobactin and kpsMT II), or both PCR and probe (all other PVFs). K2 represents isolates that
were blot positive but PCR negative for kpsMT II. K5 represents isolates with non-K1, non-K2 group II capsules. Plasmid aerobactin status was determined previously
(12). Chromosomal aerobactin status was inferred from results for iutA and plasmid aerobactin. No strain had nfaE; all strains had fimH. Results for papC and papEF
were similar to those for papAH and papG.
b
P values (by Fishers exact test) shown only where 0.10. Parentheses indicate negative association of iha with particular PVF.
c
NA, not applicable (comparison with self).
focG, hlyA
coli
Somewhat disagree
Positive vs indifferentc
Indifferent vs positived
Negative vs indifferente
Strongly disagree
(Negative vs positive f)
sfaSg,h, cvaC
a
Of the PVFs present in two or more strains each, iha and iroNE. coli were both indifferently associated with afaBC, cdtB, gafD, rfc, and ibeA but exhibited opposed
associative trends with all but rfc. PVFs which were present in 0, 1, or all 75 of the urosepsis isolates, including gafD, nfaE, fimH, and kpsMT III, were excluded from
the present analysis.
b
Positive associations of both iha and iroNE. coli with other PVFs.
c
Association with other PVFs: positive (iha), indifferent (iroNE. coli) (this also applies to papC papEF, and papG [not shown]).
d
Association with other PVFs: indifferent (iha), positive (iroNE. coli).
e
Association with other PVFs: negative (iha), indifferent (iroNE. coli).
f
Association with other PVFs: negative (iha), positive (iroNE. coli).
g
For iroNE. coli, 0.05 P 0.10.
h
For iha, 0.05 P 0.10.
papAH
papG
Allele II
Allele III
sfa/foc
sfaS
focG
afa/draBC
bmaE
gafD
hlyA
cnf1
cdtB
fyuA
iutA
iut
Plasmid
Chromosomal
kpsMT II
K1
K2
K5
kpsMT III
rfc
ibeA
cvaC
traT
PAI marker
iroNE. coli
No.
(% of total)
NOTES
TABLE 4. Distribution of papA alleles according to the presence or absence of iha and iroNE.
3045
coli
F7-1
F7-2
F8
F9
F10
F11
F12
F13
F14
F15
F16
F48
2 (3)
11 (16)
2 (3)
1 (1)
18 (27)
15 (22)
3 (4)
2 (3)
6 (9)
1 (1)
8 (12)
4 (6)
iha
iroNE. coli
Present
(n 37)
Absent
(n 30)
2 (5)
10 (27)
2 (5)
1 (3)
15 (41)
1 (3)
3 (8)
2 (5)
4 (11)
1 (3)
8 (22)
3 (8)
0
1 (3)
0
0
3 (10)
14 (47)
0
0
2 (7)
0
0
1 (3)
P valueb
0.017
0.006
(0.001)c
0.007
Present
(n 26)
Absent
(n 41)
0
6 (23)
1 (4)
0
9 (35)
5 (19)
0
2 (8)
5 (19)
0
1 (4)
1 (4)
2 (5)
5 (12)
1 (2)
1 (2)
9 (22)
10 (24)
3 (7)
0
1 (2)
1 (2)
7 (17)
3 (7)
P value
0.029
a
As determined by PCR (16). papA alleles F7-1 through F16 correspond with the traditionally recognized P fimbrial F serotypes. F48 is a recently described novel
papA allele.
b
P values (by Fishers exact test) shown only where 0.10.
c
Parentheses indicate a negative association of iha with F11.
coli
Host condition
Present
Absent
Host condition
Present
Absent
48
50
54
69
38
33f
37g
35f
31f
39g
Medical illnessc
Diabetes mellitus
Cancer
Immunosuppression
Uremia
40
50
31
46
25
64f
56g
61f
57f
59g
47
13
62
56h
(0.018)
37
38
41
39h
25
65h
(0.009)
38
39h
Any of abovee
44
77f
(0.018)
42
32f
(0.076)
(0.065)
coli
P value
0.02
0.03
The denominator for prevalence values was the number of patients with or without the indicated compromising condition.
For comparisons between patients with versus patients without the indicated type of host compromise, P values (by Fishers exact test) shown only where 0.10.
(Parentheses indicate negative associations of iha with host compromise.)
c
Including diabetes mellitus, cancer, immunosuppression, and uremia.
d
Preexisting functional or anatomic abnormality of the urinary tract.
e
Any of the above conditions, i.e., medical illness or urinary tract abnormality or instrumentation.
f
Among patients without the indicated host compromise condition, for prevalence of iha versus iroNE. coli, P 0.02 (McNemars test). Among patients with the
indicated host compromise condition, P 0.10 for all comparisons of iha versus iroNE. coli.
g
Among patients without the indicated host compromise condition, for prevalence of iha versus iroNE. coli, 0.05 P 0.10 (McNemars test). Among patients with
the indicated host compromise condition, P 0.10 for all comparisons of iha versus iroNE. coli.
h
Among patients without the indicated host compromise condition, for prevalence of iha versus iroNE. coli, and P 0.05 (McNemars test). Among patients with the
indicated host compromise condition, P 0.10 for all comparisons of iha versus iroNE. coli.
b
Associated
papA allelea
3046
NOTES
virulence genes, other explanations should be considered. Alternative mechanisms include coselection for the associated
traits (independent of these traits genetic relationship to one
another), and coselection for unmeasured traits that are genetically linked to the statistically associated putative virulence
genes. Confirmation of actual genetic linkage between putative
virulence genes would require direct genetic analyses. The
results of the present study can assist the design of such analyses by suggesting which linkages should be sought experimentally.
The significantly higher prevalence of iha found in the
present study among E. coli bacteremia isolates from noncompromised hosts than in those from compromised hosts suggests
that iha (or VFs linked to iha) may assist in overcoming host
defenses that are breached in patients with the types of compromise studied (12). In contrast, our observation that the
prevalence of iroNE. coli increased in the presence of host compromise suggests that unlike iha, iroNE. coli should be as good
a target for an anti-VF intervention among compromised hosts
as among noncompromised hosts. The absence of an association of iroNE. coli with antimicrobial resistance suggests that
iroNE. coli should also remain as effective a target for an anti-VF intervention among multidrug-resistant E. coli as among
susceptible strains, whereas iha, which was negatively associated with antimicrobial resistance, would be most useful as a
target among antimicrobial-susceptible strains.
It should be noted that the present study population represented a single geographical locale, a single clinical syndrome,
and a time period of several years in the mid-1980s. Analysis of
strains from other locales, clinical syndromes, and time periods
for iha and iroNE. coli would provide a valuable complement to
the present study.
This work was supported in part by VA Merit Review (J.R.J. and
T.A.R.); National Institutes of Health grants DK-47504 (J.R.J.), AI42059 (T.A.R.), and AI-38419 (P.I.T.); United States Department of
Agriculture grant 94-03953 (P.I.T.); and a National Cattlemens Beef
Association grant (P.I.T.).
Diana Owensby and Ann Emery helped prepare the manuscript.
REFERENCES
1. Bloch, C. A., and C. K. Rode. 1996. Pathogenicity island evaluation in Escherichia coli K1 by crossing with laboratory strain K-12. Infect. Immun. 64:
32183223.
2. Blum, G., M. Ott, A. Lischewski, A. Ritter, H. Imrich, H. Tschape, and J.
Hacker. 1994. Excision of large DNA regions termed pathogenicity islands
from tRNA-specific loci in the chromosome of an Escherichia coli wild-type
pathogen. Infect. Immun. 62:606614.
3. Boyd, E. F., and D. L. Hartl. 1998. Chromosomal regions specific to pathogenic isolates of Escherichia coli have a phylogenetically clustered distribution. J. Bacteriol. 180:11591165.
4. Donnenberg, M. S., and R. A. Welch. 1996. Virulence determinants of uropathogenic Escherichia coli. In H. L. T. Mobley and J. W. Warren (ed.),
Urinary tract infections: molecular pathogenesis and clinical management.
ASM Press, Washington, D.C.
5. Eisenstein, B. I., and G. W. Jones. 1988. The spectrum of infections and
pathogenic mechanisms of Escherichia coli. Adv. Intern. Med. 33:231252.
6. Fleiss, J. L. 1981. Statistical methods for rates and proportions. John Wiley
& Sons, New York, N.Y.
7. Groisman, E. A., and H. Ochman. 1996. Pathogenicity islands: bacterial
evolution in quantum leaps. Cell 87:791794.
8. Guyer, D. M., J.-S. Kao, and H. L. T. Mobley. 1998. Genomic analysis of a
pathogenicity island in uropathogenic Escherichia coli CFT073: distribution
of homologous sequences among isolates from patients with pyelonephritis,
cystitis, and catheter-associated bacteriuria and from fecal samples. Infect.
Immun. 66:44114417.
9. Johnson, J. R. 1991. Virulence factors in Escherichia coli urinary tract infection. Clin. Microbiol. Rev. 4:80128.
10. Johnson, J. R. 1998. papG alleles among Escherichia coli strains causing
urosepsis: associations with other bacterial characteristics and host compromise. Infect. Immun. 66:45684571.
11. Johnson, J. R., P. H. Goullet, B. Picard, S. L. Moseley, P. L. Roberts, and
W. E. Stamm. 1991. Association of carboxylesterase B electrophoretic pat-
and iroNE. coli with other PVFs from their respective PAIs in
source strains CFT073 and CP9, although statistically significant, were not absolute, evidence which suggests that the corresponding PAIs may have undergone considerable recombination over time, with acquisition or deletion of various PVF
genes, or that each PVF has independently entered multiple
different PAIs. Specific evidence of the fluidity of PAIs was
found in the discordant occurrence of iha and the PAI marker
malX (Tables 1 and 2), genes which on their shared PAI in
strain CFT073 are located within 2 kb of one another (8).
Thus, it is likely that at the same time that PAIs are generating
diversity within the species by introducing new genetic material
into disparate lineages via horizontal transfer (7), PAIs themselves are undergoing diversification through deletion and insertion of PVF genes, some of which may be more mobile (or
labile) than are the PAIs themselves. PAIs thus may exist as
continuously evolving mosaic constructs, a phenomenon which
would be predicted to confound efforts to define a reliable
marker for the PAIs of ExPEC in general or for any particular
PAI. An example of this phenomenon may be the apparent
insertion of the group III capsule genes into the group II
capsule locus in strain CP9 (24). Similarly, TAI, the PAI on
which iha was first identified, was conserved in structure in
some, but not all, diarrheagenic E. coli tested (27).
The respective patterns of phylogenetic distribution of iha
and iroNE. coli suggest divergent evolutionary histories and
mechanisms of horizontal mobility, iha was present in almost
all strains of carboxylesterase B type B2 except for those of
serotypes O1:K1:H7 and O2:K1:H7 and was also highly prevalent in selected lineages among the non-B2 strains. This is
consistent with early acquisition of iha by the B2 phylogenetic
group soon after the differentiation of B2 strains from other E.
coli (18) but after the O1:K1:H7 and O2:K1:H7 clonal group
(which constitutes a discrete evolutionary cluster within the B2
group [19]) had split off from a common B2 ancestor. In this
scenario, the appearance of iha among non-B2 strains would
require the independent acquisition of iha by non-B2 lineages
through horizontal transfer either from a B2 source or from an
unknown external source. As an alternative scenario, iha could
have entered E. coli prior to the differentiation of the B2
phylogenetic group and subsequently have been deleted from
the ancestor of the O1:K1:H7 and O2:K1:H7 branch of the B2
group after the differentiation of this branch from other B2
strains. In this scenario, iha could have been inherited vertically from a common ancestor by both B2 and certain non-B2
strains, for example, those of closely related phylogenetic
group D (18).
In contrast to iha, the sporadic appearance of iroNE. coli in
many different serotypes strongly suggests either multiple horizontal acquisition events or multiple scattered deletions of
iroNE. coli within otherwise iroNE. coli-positive lineages. Although in strain CP9 iroNE. coli occurs on a genomic PAI (23),
the possibility of plasmid-associated transfer of iroNE. coli in
some strains was suggested in the present study by the striking
statistical association of iroNE. coli with cvaC (colicin V), which
occurs on large conjugative plasmids (2830). Precedent in
ExPEC for a siderophore system which occurs variously on
colicin V plasmids and on the genome is provided by the
aerobactin system, which has been postulated to represent an
extinct transposon (22, 28). The finding that in strain CP9
iroNE. coli is flanked by IS1230 sequences (23) suggests the
possibility of independent mobility of iroNE. coli, which would
be consistent with exchange of iroNE. coli between genome and
plasmids.
Although direct genetic linkage is a plausible explanation for
the observed statistical associations between different putative
INFECT. IMMUN.
12.
13.
14.
15.
16.
18.
19.
20.
21.
Editor: E. I. Tuomanen
22.
23.
24.
25.
26.
27.
28.
29.
30.
3047
17.
NOTES